Navigation Links
Blue Belt Technologies Announces Golden Jubilee National Hospital Completes Initial NavioPFS Unicondylar Knee Replacement Surgery
Date:12/7/2012

PITTSBURGH, Dec. 7, 2012 /PRNewswire/ -- Blue Belt Technologies, Inc. announces the first NavioPFS™ unicondylar knee replacement (UKR) procedure performed at the Golden Jubilee National Hospital in Glasgow, Scotland on December 6, 2012. Dr. Fred Picard successfully performed the surgery using the NavioPFS surgical system. Dr. Picard is a renowned orthopedist and past winner of the Muller Award from the CAOS (Computer Assisted Orthopaedic Surgery) International Society.

The NavioPFS surgical system provides a smart instrument with robotic control, intraoperative implant planning and 3D visualization and navigation to the surgeon in treatment of knee osteoarthritis. Utilizing proprietary software and patented robotic technology, the NavioPFS plans and executes precision bone resection for optimal placement of UKR implants.

After completing the case, Dr. Picard commented "The NavioPFS system met and exceeded my expectations in allowing me to achieve the precise implantation required for unicondylar knee replacement surgery. I was very pleased to have the opportunity to introduce this technology to the Golden Jubilee community."

The Golden Jubilee is a national joint center of excellence in Scotland, specializing in orthopedics, cardiology, ophthalmology and general surgery. The Golden Jubilee is responsible for as much as 25% of the orthopedic (arthroplasty) surgical volume in Scotland, and presents an excellent opportunity to showcase the NavioPFS system to other users around the United Kingdom and Europe.

Commenting on the procedure, Eric B. Timko, President and CEO of Blue Belt Technologies, said, "We are excited to begin the next phase of work with Dr. Picard and the Golden Jubilee Hospital as additional surgeons become trained and start using the NavioPFS system to treat patients with unicompartmental osteoarthritis. We believe the NavioPFS system offers a precise and repeatable technique for performing a traditionally very difficult surgery, in an economical package that makes the technology available to any geographic market and hospital system."

Blue Belt Technologies, Inc.

Blue Belt Technologies, Inc. is developing the next generation of "smart" surgical instruments with precision robotics for use initially in orthopedic procedures and then for other surgical specialties, including neurosurgery, spinal and otolaryngology (ENT). The company's NavioPFS System incorporates patented technology to provide precise robotic control to surgeons via an intelligent, handheld, computer-assisted bone-cutting tool. The NavioPFS System provides the surgeon with a layer of safety and enhanced accuracy while performing bone-shaping tasks through minimally invasive incisions.

BLUE BELT TECHNOLOGIES, INC.


'/>"/>
SOURCE Blue Belt Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
2. SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the Worlds First Prototype for its Next Generation Application for Drug Safety Administration
3. OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer
4. Innovative CA Tumor Marker Tests Technologies and Emerging Markets
5. BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
6. UV Flu Technologies Signs a Distribution Agreement with DPG Distribution
7. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
8. DenMat Announces Signing a Purchase Agreement to Acquire PeriOptix Inc., Leading Provider of Magnification and Illumination Technologies
9. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
10. CLAAD Selects Egalet As Top Five Technologies To Reduce Prescription Drug Abuse Honoree
11. CLAAD Highlights 5 Technologies To Reduce Prescription Drug Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets has ... - 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies ... market. The research answers the following questions: ... attributes? How are they positioned in the Global Menopause market? ...
(Date:2/23/2017)... CITY, Calif. , Feb. 23, 2017 /PRNewswire/ ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that it will release fourth ... on Thursday, March 2nd, 2017. AcelRx management will ... Eastern Time (1:30 p.m. Pacific Time) on March ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Global ... report to their offering. ... The Global Endoscopy Market is poised to grow at ... approximately $47.6 billion by 2025. This industry report ... on global as well as regional levels presented in the research ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... clinician-based audience, will be participating in Rare Disease Day events, hosted by the ... addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, will be ...
(Date:2/23/2017)... Fair Lawn, NJ (PRWEB) , ... February 23, ... ... specializing in thought leadership , media relations, content marketing, social media ... Vermont. With several clients already in the state and in nearby New Hampshire, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing LLC ... converge and explore the world from different perspectives. By providing a place for ... gain understanding, increase empathy, and find greater happiness. , "Our approach to ...
(Date:2/23/2017)... Lincoln, RI (PRWEB) , ... February 23, 2017 ... ... announced today a new partnership with the Rhode Island Consortium for Autism Research ... provide an opportunity for children with autism spectrum disorder (ASD) to see films ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today ... efficacy of CM-AT in children aged 3-8 with Autism, is now enrolling at three ... enrolling children across the United States. , “There are currently no approved drugs ...
Breaking Medicine News(10 mins):